Showing results (351-360 of 362) with videos related to
Sort By:
Pageof 37
The Lancet. Oncology|August 13, 2019
Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialCristina Saura, Dominik Hlauschek, Mafalda Oliveira, et al.International Journal of MS Care|November 12, 2020
An International Standardized Magnetic Resonance Imaging Protocol for Diagnosis and Follow-up of Patients with Multiple Sclerosis: Advocacy, Dissemination, and Implementation StrategiesLori Saslow, David K B Li, June Halper, et al.Elife|October 17, 2015
An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin in zebrafishJun Zou, Diana Tran, Mai Baalbaki, et al.Nature|October 30, 2012
HIV therapy by a combination of broadly neutralizing antibodies in humanized miceFlorian Klein, Ariel Halper-Stromberg, Joshua A Horwitz, et al.Biorxiv : the Preprint Server for Biology|May 27, 2024
Moesin controls cell-cell fusion and osteoclast functionOphélie Dufrancais, Perrine Verdys, Marianna Plozza, et al.The Journal of Cell Biology|October 27, 2025
Moesin controls cell-cell fusion and osteoclast functionOphélie Dufrançais, Marianna Plozza, Marie Juzans, et al.Science Translational Medicine|January 20, 2017
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controllerNatalia T Freund, Haoqing Wang, Louise Scharf, et al.Neurology|September 29, 2022
International Recommendations for the Diagnosis and Management of Patients With Adrenoleukodystrophy: A Consensus-Based ApproachMarc Engelen, Wouter J C van Ballegoij, Eric James Mallack, et al.The Lancet. Neurology|September 20, 2025
2024 MAGNIMS-CMSC-NAIMS consensus recommendations on the use of MRI for the diagnosis of multiple sclerosisFrederik Barkhof, Daniel S Reich, Jiwon Oh, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 7, 2021
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)Michael Gnant, Amylou C Dueck, Sophie Frantal, et al.Pageof 37